Alkermes company specific news: Any announcements regarding drug development, clinical trial results, regulatory approvals or rejections, and commercialization efforts for Alkermes' pharmaceutical products will heavily influence stock price.

Pharmaceutical Industry trends: The overall performance and sentiment towards the biotechnology and pharmaceutical industries impact ALKT.US. Positive industry trends such as innovation, successful drug launches, and favorable regulatory changes tend to lift the stock.

Overall market conditions: General economic conditions, investor sentiment, and broader market indices (e.g., S&P 500) can affect all stocks, including ALKT.US. Economic downturns or market volatility can lead to price decreases.

Financial performance: Alkermes' revenue, earnings, profitability, and cash flow directly affect investor confidence. Strong financial results typically lead to price increases, while weak results often cause price decreases.

Competition: The competitive landscape within the pharmaceutical market, including competing drugs and therapies, affects Alkermes' market share and pricing power, which in turn impacts the stock.

Regulatory environment: Changes in regulations related to drug approvals, pricing, and reimbursement policies impact Alkermes. Stricter regulations can negatively affect the stock.

Analyst ratings and price targets: Recommendations and price targets from financial analysts can influence investor perception and trading activity, thereby affecting the stock price.

Management and strategy: Investors evaluate the effectiveness of Alkermes' management team and their strategic decisions regarding research, development, and acquisitions, which can influence the stock price.

Patent protection: The strength and duration of Alkermes' patents for its key products are critical, as patent expirations can lead to generic competition and reduced revenue.

Healthcare policy changes: Changes in healthcare policies, such as the Affordable Care Act or drug pricing regulations, have a significant impact on pharmaceutical companies and their stock values.